Hypoxia, leukocytes, and the pulmonary circulation.

Area of Science:

• Pulmonary Hypertension Research
• Cellular and Molecular Medicine
• Cardiovascular Pathophysiology

Background:

• Chronic hypoxia is linked to pulmonary hypertension.
• Circulating monocytes and fibrocytes are implicated in this process.
• Leukocyte recruitment to the pulmonary circulation is a key event.

Purpose of the Study:

• Investigate the role of circulating monocytes and fibrocytes in hypoxic pulmonary hypertension.
• Elucidate the mechanisms of leukocyte recruitment and pulmonary vessel remodeling.
• Explore the contribution of these cells to neovascularization.

Main Methods:

• Analysis of hypoxic animal models.
• Examination of chemokine and growth factor expression in pulmonary vessels.
• Assessment of bone marrow progenitor cell release and receptor expression.
• Evaluation of macrophage/fibrocyte effects on resident cells and extracellular matrix production.

Main Results:

• Hypoxia induces chemokine expression (MCP-1, SDF-1) and growth factors (VEGF-A, ET-1, TGF-β1) in pulmonary vessels.
• Increased release of monocytic progenitors from bone marrow with upregulated chemokine receptors.
• Macrophages/fibrocytes stimulate proliferation, migration, and phenotypic modulation of resident cells.
• These cells contribute to collagen production, myofibroblast differentiation, and vasa vasorum neovascularization.

Conclusions:

• Circulating monocytes and fibrocytes are critical players in hypoxic pulmonary hypertension.
• They drive pulmonary vascular remodeling through paracrine effects and direct contributions.
• A feedforward loop involving neovascularization exacerbates the pathological process.
• Further research is needed to define specific mechanisms and therapeutic targets.